Antitumor activity of IDN 5109, a new taxane, on human ovarian carcinoma xenografts

被引：0
|
作者：
Rossi, C
Mincione, T
Nicoletti, I
Bombardelli, E
Riva, A
Donati, MB
Giavazzi, R
机构：
[1] Consorzio Mario Negri Sud, Chieti, Italy
[2] Mario Negri Inst Pharmacol Res, I-24100 Bergamo, Italy
[3] Indena SPA, I-20141 Milan, Italy
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
349
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [21] Hyaluronic acid-paclitaxel: Antitumor efficacy against CD44(+) human ovarian carcinoma xenografts
    Auzenne, Edmond
    Ghosh, Sukhen C.
    Khodadadian, Mojgan
    Rivera, Belinda
    Farquhar, David
    Price, Roger E.
    Ravoori, Murali
    Kundra, Vikas
    Freedman, Ralph S.
    Klostergaard, Jim
    NEOPLASIA, 2007, 9 (06): : 479 - 486
  • [22] A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts
    Polizzi, D
    Pratesi, G
    Tortoreto, M
    Supino, R
    Riva, A
    Bombardelli, E
    Zunino, F
    CANCER RESEARCH, 1999, 59 (05) : 1036 - 1040
  • [23] ANTITUMOR-ACTIVITY OF ORALLY-ADMINISTERED AMMINE AMINE PLATINUM (IV) DICARBOXYLATE COMPLEXES AGAINST A PANEL OF HUMAN OVARIAN-CARCINOMA XENOGRAFTS
    KELLAND, LR
    JONES, M
    GWYNNE, JJ
    VALENTI, M
    MURRER, BA
    BARNARD, CFJ
    VOLLANO, JF
    GIANDOMENICO, CM
    ABRAMS, MJ
    HARRAP, KR
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1993, 2 (06) : 1043 - 1048
  • [24] Antitumor activity of irofulven against human ovarian cancer cell lines, human tumor colony-forming units, and xenografts
    Van Laar, ES
    Izbicka, E
    Weitman, S
    Medina-Gundrum, L
    Macdonald, JR
    Waters, SJ
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2004, 14 (05) : 824 - 831
  • [25] Antitumor Properties of Cyclooxygenase Inhibitors in Combination with Taxol in Human Ovarian Cancer Xenografts
    Li, W.
    Wang, J.
    Zhai, L. Y.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 761 - 761
  • [26] Combination of IDN5390, an orally active taxane, with paclitaxel in a human tumor xenograft: improvement in antitumor efficacy without increase of toxicity
    Pratesi, G
    Laccabue, D
    Tortoreto, M
    Bombardelli, E
    Riva, A
    Morazzoni, P
    Zunino, F
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S43 - S43
  • [27] Cooperative antitumour activity of a novel Protein kinase A antisense with the specific EGFR tyrosine kinase inhibitor ZD1839 (Iressa™) and the taxane IDN5109 following oral administration.
    Tortora, G
    Caputo, R
    Damiano, V
    De Placido, S
    Zunino, F
    Bianco, AR
    Ciardiello, F
    CLINICAL CANCER RESEARCH, 2000, 6 : 4562S - 4562S
  • [28] ANTITUMOR EFFICACY OF TAXANE LIPOSOMES ON A HUMAN OVARIAN TUMOR XENOGRAFT IN NUDE ATHYMIC MICE
    SHARMA, A
    STRAUBINGER, RM
    OJIMA, I
    BERNACKI, RJ
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (12) : 1400 - 1404
  • [29] RADIOIMMUNOTHERAPY OF HUMAN OVARIAN-CARCINOMA XENOGRAFTS - PRELIMINARY EVALUATION
    WAHL, RL
    LIEBERT, M
    FISHER, S
    SHERMAN, P
    JACKSON, G
    LAINO, L
    WISSING, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 384 - 384
  • [30] Marked antitumor activity of S23906 in a new therapeutic model of ovarian carcinoma
    Kraus-Berthier, Laurence
    David, Geraldine
    Beaudenon-Chacun, Christine
    De Montrion, Catherine
    Bertrand-Kermorgant, Francoise
    Pierre, Alain
    CANCER RESEARCH, 2006, 66 (08)
12345